Neuberger Berman Group LLC Apellis Pharmaceuticals, Inc. Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q1 2024
A detailed history of Neuberger Berman Group LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 10,675 shares of APLS stock, worth $399,672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,675Holding current value
$399,672% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding APLS
# of Institutions
336Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$564 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$425 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$416 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$356 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$206 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.11B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...